[HTML][HTML] Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”

DS Karpov, AO Sosnovtseva, SV Pylina… - International Journal of …, 2023‏ - mdpi.com
Type 1 diabetes mellitus (T1D) is an autoimmune disease caused by the destruction of
insulin-producing β-cells in the pancreas by cytotoxic T-cells. To date, there are no drugs …

Exploring cutting-edge approaches in diabetes care: from nanotechnology to personalized therapeutics

GF Asaad, AS Doghish, AA Rashad… - Naunyn-Schmiedeberg's …, 2024‏ - Springer
Diabetes mellitus (DM) is a persistent condition characterized by high levels of glucose in
the blood due to irregularities in the secretion of insulin, its action, or both. The disease was …

In vitro generation of transplantable insulin-producing cells from canine adipose-derived mesenchymal stem cells

Q Dang Le, W Rodprasert, S Kuncorojakti… - Scientific reports, 2022‏ - nature.com
Canine mesenchymal stem cells (cMSCs) have potential applications for regenerative
therapy, including the generation of insulin-producing cells (IPCs) for studying and treating …

Silencing of forkhead box protein O-1 (FOXO-1) enhances insulin-producing cell generation from adipose mesenchymal stem cells for diabetes therapy

MM Kamal, RA Ammar, DH Kassem - Life Sciences, 2024‏ - Elsevier
Aims Generation of mature β-cells from MSCs has been a challenge in the field of stem cell
therapy of diabetes. Adipose tissue-derived mesenchymal stem cells (Ad-MSCs) have made …

The progress of pluripotent stem cell-derived pancreatic β-cells regeneration for diabetic therapy

X Wang, M Gao, Y Wang, Y Zhang - Frontiers in endocrinology, 2022‏ - frontiersin.org
Diabetes is a complex metabolic disorder of carbohydrate metabolism, characterized by
high blood glucose levels either due to an absolute deficiency of insulin secretion or an …

Nanoparticle-mediated CRISPR/dCas9a activation of multiple transcription factors to engineer insulin-producing cells

MH Lee, JL Thomas, CY Lin, YCE Li… - Journal of Materials …, 2023‏ - pubs.rsc.org
Insulin may help to control blood glucose levels in diabetes; however, the long-term release
of insulin is important for therapy. In this work, four guide RNAs (gRNA) for factors that …

Identification of ferroptosis‐related genes in type 2 diabetes mellitus based on machine learning

S Wang, Y Lu, T Chi, Y Zhang, Y Zhao… - Immunity …, 2023‏ - Wiley Online Library
Background Type 2 diabetes mellitus (T2DM), which has a high incidence and several
harmful consequences, poses a severe danger to human health. Research on the function …

Recent advances in the generation of β-cells from induced pluripotent stem cells as a potential cure for diabetes mellitus

A Agrawal, G Narayan, R Gogoi… - Cell Biology and …, 2021‏ - Springer
Diabetes mellitus (DM) is a group of metabolic disorders characterized by high blood
glucose levels due to insufficient insulin secretion, insulin action, or both. The present-day …

Exploring biomarkers and transcriptional factors in type 2 diabetes by comprehensive bioinformatics analysis on RNA-Seq and scRNA-Seq data

Y Huang, L Cai, X Liu, Y Wu… - Annals of Translational …, 2022‏ - pmc.ncbi.nlm.nih.gov
Background Type 2 diabetes (T2D) is a prevalent chronic disease with elusive. Combining
transcriptome and single-cell sequencing data to explore biomarkers of T2D could provide …

[HTML][HTML] An artificial intelligence prediction model of insulin sensitivity, insulin resistance, and diabetes using genes obtained through differential expression

JM González-Martín, LB Torres-Mata, S Cazorla-Rivero… - Genes, 2023‏ - mdpi.com
Insulin is a powerful pleiotropic hormone that affects processes such as cell growth, energy
expenditure, and carbohydrate, lipid, and protein metabolism. The molecular mechanisms …